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Fig. 1. Chest computed tomography shows a 6×7 cm, well-en-
hanced round mass containing multiple calcifications in the left ret-
roperitoneal area.
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Castleman’s disease is a rare disorder characterized by benign tumors that may develop in the lymph node tissue 
throughout the body. Castleman’s disease associated with myasthenia gravis is an especially rare disease. Only 
less than 10 cases have been reported in the world literature. The cause of Castleman’s disease is associated 
with immune mediated reaction, and myasthenia gravis also develops due to an antibody-mediated process. The 
cause of myasthenia gravis is the immune activity of Castleman’s disease, which may be the promoter of the anti-
body-mediated process. We report here a case of Castleman’s disease, which was incidentally found in a patient 
diagnosed with myasthenia gravis.




A 51-year-old male was admitted to the hospital complain-
ing  of  ptosis,  dysarthria,  difficult  mastication,  and  general 
weakness  for  2 months.  The circulating  antibody against  ace-
tylcholine  receptor  serum  was  markedly  elevated.  The  find-
ings  of  repeated  nerve  stimulation  tests  and  single  fiber  elec-
tromyography  were  consistent  with  the  diagnosis  of  myasthe-
nia  gravis.  The  chest  computed  tomography  (CT)  scan  re-
vealed  a  6×7  cm  left  retroperitoneal  mass  (Fig.  1),  and  the 
thymus  gland  was  not  shown  as  enlarged,  therefore,  indicat-
ing  thymic  hyperplasia.  We  performed  ultrasono-guided  nee-
dle  biopsy  to  confirm  the  diagnosis  of  the  retroperitoneal 
m a s s .  T h e  p a t h o l o g i c a l  f i n d i n g s  w e r e  s u s p i c i o u s  f o r  c o r t i c a l  
type  ectopic  thymoma.
We concluded that the myasthenia gravis developed due to 
ectopic  thymoma  or  thymus.  A  retroperitoneal  mass  excision Sang-Kwon Lee, et al
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Fig. 2. The microscopic findings show an increased number of 
lymphoid follicles with small, involuted, and partly collagenized ger-
minal centers (H&E, ×40).
and  thymectomy  were  performed  in  order  to  relieve  the 
myasthenic  symptoms.  The  thoracotomy  was  first  performed 
in  the  11th  intercostal  space,  and  a  9×10  cm  mass  was  lo-
cated  in  the  retroperitoneal  space  adjacent  to  the  left  kidney; 
the  mass  was  excised.  We  then  changed  the  position  for  the 
sternotomy,  and  the  thymus  gland  and  pericardial  fat  tissue 
were  removed.  The  pathologic  findings  of  the  thymus  sug-
gested  normal  thymic  tissue;  there  were  no  hyperplasia,  in-
flammatory  changes,  or  malignancies.  The  retroperitoneal 
mass  showed  a  variant  of  hyaline-vascular  type  Castleman’s 
disease  (Fig.  2).  After  the  surgery,  muscle  strength  dramati-
cally  improved  for  six  months;  however,  the  symptoms  re-
curred and were gradually aggravated. The patient was treated 
with  steroids,  and  plasmapheresis  was  performed.
DISCUSSION
Castleman's  disease  is  a  rare  disorder  characterized  by  be-
nign  tumors  that  may  develop  in  the  lymph  node  tissue 
throughout the body. In some cases it is associated with vari-
ous  clinical  conditions;  Castleman’s  disease  associated  with 
myasthenia  gravis  is  especially  rare  [1].  Only  less  than  10 
cases  have  been  reported  in  the  world  literature.
Myasthenia  gravis  is  associated  with  an  antibody-mediated 
process.  Antibodies  reduce  the  number  of  acetylcholine  re-
ceptors  according  to  three  principle  mechanisms:  accelerated 
endocytosis  and  degradation  of  the  acetylcholine  receptors, 
functional  blockade  by  the  antibody  on  the  acetylcholine  re-
ceptors,  and  complement-mediated  damage  to  the  acetylcho-
line  receptors.  In  particular,  the  antibody-mediated  process 
was  developed  by  autoimmune  reaction  [2].  Castleman’s  dis-
ease  has  been  implicated  in  immune  alterations.  The  over-
production  of  cytokines  and  interleukin  is  believed  to  play  a 
central role in the development of Castleman’s  disease and it 
is also associated with many clinical conditions related to im-
mune  disease  [3].  The  immune  activity  of  Castleman’s  dis-
ease  may  be  the  promoter  of  the  antibody-mediated  process 
of  myasthenia  gravis  [4].
Castleman’s  disease  cases  associated  with  myasthenia 
gravis  were  mostly  of  the  hyaline-vascular  type.  Of  all  the 
cases  reported  in  the  literature, t h r e e  w e r e  t h e  m u l t i - c e n t r i c  
type;  the  others  were  the  localized  type.  There  was  no  evi-
dence  of  hyperplasia  or  malignancy  of  the  thymus  in  any  of 
the  cases.  One  case  was  combined  with  other  clinical  symp-
toms including paraneoplastic pemphigus and bronchiolitis ob-
literans  [4-7].
Surgical  results  have  varied.  Emson  [5]  reported  on  a 
14-year-old  girl  who  had  undergone  an  incomplete  resection 
of  a  retroperitoneal  mass  and  a  thymectomy;  she  had  im-
proved  slightly.  Chorzelski  et  al.  [6]  reported  on  a  case  of 
Castleman’s  disease  with  myasthenia  gravis,  paraneoplastic 
pemphigus,  and  bronchiolitis  obliterans;  the  tumor  was  re-
sected  incompletely  without  thymectomy.  Although  myasthe-
nia  gravis  was  controlled  with  medication,  the  patient  died 
due  to  aggravation  of  bronchiolitis  obliterans,  which  had  de-
veloped  due  to  the  deposition  of  immunoglobulin  G  to  the 
bronchus.  Pasaoglu  et  al.  [4]  reported  on  multicentric  Castle-
man’s  disease  that  was  completely  removed  by  thymectomy. 
The  patient  immediately  responded  to  surgery,  but  after  sev-
eral  months,  the  symptoms  recurred  and  plasmapheresis  was 
needed.  In  our  case,  after  complete  resection  of  Castleman’s 
node and thymectomy, muscle strength dramatically improved 
in the immediate postoperative period, but symptoms recurred 
after  3  months.  According  to  these  results,  it  is  controversial 
to  perform  thymectomy  for  the  treatment  of  Castleman’s  dis-
ease  associated  with  myasthenia  gravis.  However,  at  mini-
mum  the  excision  of  Castleman’s  lymph  node  is  necessary.Castleman’s Disease with Myasthenia Gravis
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